secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2026-09-16T21:30:31+00:00
Accession:  0001493152-26-042963
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ernexa Therapeutics posts corporate fact sheet and investor presentation; no specifics disclosed
--------------------------------------------------------------------------------

- Ernexa Therapeutics (ERNA) made available a corporate fact sheet and investor presentation dated September 16, 2026, via website and SEC filing.
- No financial or operational data appears in the exhibits of this filing; specific content not provided.
- Materials made available on company website on September 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315226042963/0001493152-26-042963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315226042963/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer